| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT01167738 2010-020979-23 Details | 2015-04-24 Interventional | 2 | 60 | Capecitabine Epirubicin Gemcitabine Metformin Pancreatic Neop… Pancreatic Canc… | concern of detrimental effect - | |||
| NCT01039610 Details | 2015-04-22 Interventional | 1 | 0 | Linezolid Moxifloxacin Bacterial Infec… Infections, Bac… | Internal decision to progress alternate molecule with more preferable profile - | |||
| NCT01593319 2011-003326-27 Details | 2015-04-21 Interventional | 4 | [5 Refs] | 37 | Ropivacaine Hip Fractures | - - | ||
| NCT01492725 Details | 2015-04-21 Interventional | 2 | 70 | Plasminogen Tissue Plasmino… Ischemic Stroke | On DSMB advice, trial recruitment has been halted for efficacy. F/U continues - | |||
| NCT01404767 Details | 2015-04-21 Interventional | 4 | 20 | Esmolol Metoprolol Heart Diseases Vascular Diseas… Angina Cardiac Disease Hypertension Vascular Diseas… | Enrollment slow over 2 years a change in the population less on metoprolol than initially
anticipated - | |||
| NCT00832364 Details | 2015-04-21 Interventional | 4 | 0 | Acitretin Etanercept Psoriasis Plaque Psoriasi… | Business decision. No patients were enrolled - | |||
| NCT00713947 Details | 2015-04-21 Interventional | 4 | 0 | Amoxicillin Clarithromycin Metronidazole Pantoprazole Coronary Thromb… Thrombosis Positive Helico… Supra-aortic Ar… | no inclusion - | |||
| NCT00361413 Details | 2015-04-21 Interventional | 3 | 26 | Alefacept Graft vs Host D… Graft Versus Ho… | company withdrawal of the drug - | |||
| NCT00278018 Details | 2015-04-21 Interventional | 1/2 | - | Immunomodulatin… Skin Neoplasms Cancer of Skin Solid Tumors | Because there were no responses - | |||
| NCT00093314 Details | 2015-04-21 Interventional | 1/2 | 0 | Ofatumumab Leukemia Leukemia, Lymph… Leukemia, Lymph… Chronic Lymphoc… | Acquired asset - | |||
| NCT00092274 Details | 2015-04-21 Interventional | 1/2 | 0 | Ofatumumab Lymphoma Lymphoma, Folli… | Acquired asset - | |||
| NCT00424775 Details | 2015-04-20 Interventional | 1 | 3 | Vorinostat Carcinoma, Non-… Lung Neoplasms Neoplasms | - - | |||
| NCT00891761 Details | 2015-04-17 Interventional | 3 | 0 | BB 1101 Casopitant Dexamethasone Dexamethasone a… Ondansetron Nausea Vomiting Cancer Chemotherapy-In… Nausea and Vomi… Solid Tumor Can… | This study has been cancelled prior to enrollment. - | |||
| NCT00884533 Details | 2015-04-17 Interventional | 1 | 0 | Moxifloxacin Alzheimer Disea… Alzheimer's Dis… | The whole project was terminated - | |||
| NCT00814372 Details | 2015-04-17 Interventional | 2 | 242 | Metformin Diabetes Mellit… Diabetes Mellit… Type 2 Diabetes… | MBX-102 did not meet the target efficacy profile of HbA1c change. - | |||
| NCT00456313 Details | 2015-04-17 Interventional | 4 | 0 | Fluticasone Fluticasone-Sal… Asthma | lack of data - | |||
| NCT00332319 Details | 2015-04-17 Interventional | 2 | 1 | Casopitant Enuresis Spinal Cord Inj… Urinary Bladder… Urinary Inconti… Incontinence, U… Overactive Blad… | - - | |||
| NCT00319332 NCT00078676 Details | 2015-04-17 Interventional | 3 | 0 | Tositumomab I-1… Lymphoma Lymphoma, Folli… Lymphoma, Non-H… Lymphoma, Large… Lymphoma, Small… | This study has been cancelled prior to enrollment - | |||
| NCT01615822 Details | 2015-04-16 Interventional | 1 | 25 | Artefenomel Malaria | Decision taken to halt progression of mefloquine as a potential partner for OZ439 as a single
dose cure due to low probability of success - | |||
| NCT00503763 Details | 2015-04-16 Interventional | 2 | 0 | Simvastatin Multiple Myelom… Neoplasms, Plas… Smoldering Mult… | We found out that there is another study on the same issue - |